Antimicrobial Polypeptides Enhancing Stability and Broad-Spectrum Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial peptides lack effective solutions for broad-spectrum activity against both Gram-positive and Gram-negative bacteria and fungi, with existing peptides often having limited stability and specificity.
Innovation Solution
Development of isolated polypeptides with at least 70% identity to the amino acid sequence of SEQ ID NO:2, which exhibit antimicrobial activity by inhibiting microbial growth and killing microbial cells, and methods for producing and using these polypeptides through recombinant host cells and nucleic acid constructs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing antimicrobial peptides are used, then they can kill or inhibit microbial cells, but they lack broad-spectrum activity and have limited stability
Solution Approach 1:
The patent modifies the amino acid sequence parameters of existing antimicrobial peptides to create novel polypeptides with improved stability while maintaining or enhancing broad-spectrum antimicrobial activity. Specifically, the invention identifies and modifies critical amino acid residues in the peptide sequence to increase metabolic stability and resistance to proteolytic degradation, while preserving the ability to interact with diverse microbial targets.
Solution Approach 2:
The patent creates composite antimicrobial polypeptides by combining functional domains from different peptide sources or by fusing antimicrobial sequences with stabilizing structural elements. This approach generates hybrid molecules that exhibit both enhanced stability and broad-spectrum activity against Gram-positive and Gram-negative bacteria as well as fungi.
2Adaptability or versatility
If existing antimicrobial peptides are used, then they can inhibit microbial growth, but they lack specificity
Solution Approach 1:
The patent introduces localized modifications to specific regions of the antimicrobial peptide sequence that enhance target recognition and binding affinity. By optimizing the local chemical and structural properties of key functional domains, the polypeptides achieve higher specificity for microbial targets while reducing off-target effects on host cells and beneficial microorganisms.
Solution Approach 2:
The patent creates refined copies of natural antimicrobial peptides with optimized sequences that maintain the core functional motifs responsible for specificity while eliminating or modifying regions that contribute to non-specific toxicity. These engineered copies preserve the ability to selectively target pathogenic microbes while minimizing collateral damage.
3Productivity
If recombinant production methods are used, then polypeptides can be produced at scale, but production complexity increases
Solution Approach 1:
The patent extracts and isolates only the essential coding sequence for the antimicrobial polypeptide, separating it from complex regulatory elements and flanking sequences. This streamlined genetic construct can be directly inserted into standard expression vectors and host cells, simplifying the recombinant production process while enabling scalable manufacturing.
Solution Approach 2:
The patent designs the polypeptide sequence and expression construct to be universally compatible with multiple host systems and production platforms. The modular design allows the same coding sequence to be expressed in various bacterial, yeast, or mammalian cell lines, providing flexibility and reducing the need for system-specific optimization.
Data Source
AI summary
The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.